Clinical aspects of nicotine dependence and depression

Medicine Today

Volumn 5, Issue 1, 2004, Pages 40-46

  Wilheim, Kay ^a,b,d   Richmond, Robyn ^c   Wodak, Alex ^a,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d BLACK DOG INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NICABATE CQ; NICORETTE CHEWING GUM; NICORETTE PATCH; NICOTINE; NICOTINE GUM; NICOTINELL CHEWING GUM; NORTRIPTYLINE; QUITX CHEWING GUM; QUITX PATCH; ZYBAN SR;

ANGER; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; EMOTIONAL STABILITY; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HUMAN; IRRITABILITY; NICOTINE REPLACEMENT THERAPY; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PHYSICIAN ATTITUDE; PREVALENCE; PROBLEM SOLVING; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RELAPSE; RISK ASSESSMENT; SMOKING CESSATION; SYMPTOM; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 1042304204     PISSN: 1443430X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fiore M. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. JAMA 2000; 283: 3244-3254.
2. Hughes JR, Fiester S, Goldstein M, Resnick M, Rock N, Ziedonis D. Practice guidelines for the treatment of nicotine dependence. Am J Psychiatry 1997; 153(Suppl): 1-31.
3. Peters M, Morgan L. The pharmacotherapy of smoking cessation. Med J Aust 2002; 176: 486-490.
4. Benowitz N. Nicotine pharmacology and addiction. In: Benowitz N, ed. Nicotine safety and toxicity. New York: Oxford University Press, 1998.
5. Benowitz N. Cardiovascular toxicity of nicotine: pharmacokinetic and pharmacodynamic considerations. In: Benowitz N, ed. Nicotine safety and toxicity. New York: Oxford University Press, 1998.
6. Karan L, Rosecrans J, PiaseckiM, Newhouse P. Addictive capacity of nicotine. In: Piasecki M, Newhouse P, eds. Nicotine in psychiatry: psychopathology and emerging therapeutics. Washington, DC: American Psyhiatric Press, 2000.
7. Jarvis M, Wardle J, Waller J, Owen L. Prevalence of hardcore smoking in England, and associated attitudes and beliefs: cross sectional study. BMJ 2003; 326: 1061-1065.
8. Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence andcorrelates of DSM-IV major depression in an Australian national survey. J Affective Disorders 2003; 75: 155-162.
9. Breslau N, Peterson E, Schultz L, Chilcoat H, Andreski P. Majore depression and stages of smoking: a longitudinal investigation. Arch Gen Psychiatry 1998; 55: 161-165.
10. Tanskanen A, Viinamaki H, Hintikka J, Koivumaa-Hnkanen H-T, Lehtonen J. Smoking and suicidality among psychiatric patients. Am J Psychiatry 1998; 155: 129-130.
11. Kirch D. Niotine and major mental disorders. In: Piasecki M, Newhouse P, eds. Nicotine in psychiatry: psychopathology and emerging therapeutics. Washington, DC: American Psychiatric Press, 2000: 111-131.
12. Heartherton TK, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagestrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addiction 1991; 86: 1119-1127.
13. Hughes JR, Stead L, Lancaster T. Antidepressants for smoking cessation (Cochrane Review). The Cochrane Library, Issue 4, 2003. Chichester: John Wiley & Sons, Ltd.
14. Chengappa K, Kambhanpati R, Perkins K, et al. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhbitor antidepressants. J Clin Psychiatry 2001; 62: 503-508.
15. Richmond R, Zwar N. Review of bupropion for smoking cessation. Drug Alcohol Rev 2003; 22: 203-220.
16. Jorenby D, Scott, JL, Nides, MA, et al. A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691.
17. Hall S, Reus V, Munoz R, et al. Nortiptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998; 55: 683-690.
18. Griffiths K, Christensen, H, Hawking, D, Jorm, A, Blue pages. Canberra: Centre for Mental Health Research, Australian National University, 2001 (222.bluepages.anu.edu.au).
19. Wilson D, Ciliska, D. Lifesyle assessment: development and use of the FANTASTIC checklist. Can Fam Physician 1984; 30: 1527-1532.